Gregory Critchfield

Dr. Gregory Critchfield received a Bachelor's Degree in Microbiology with a minor in Chemistry from Brigham Young University in 1976, an MD degree from the University of Utah in 1980, and a master's degree in Biophysical Sciences at the University of Minnesota in 1985. There he also completed fellowships in Clinical Chemistry and in Health Information Sciences sponsored by the National Library of Medicine and boarded in Clinical Pathology. He served as a reviewer and study section chair for the NIH for over 15 years in biomedical computing programs for SBIR, STTR and R01 programs. His research has focused on building quantitative models in many areas of laboratory medicine including anticoagulation control, method standardization, mass spectrometric identification of drugs, predictive value modeling, quantitative health policy analysis and clinical genetics. He has served on the faculty of three medical schools: University of Minnesota, Wayne State University and Duke University. He worked as a practicing clinical pathologist with Intermountain Healthcare for nine years. He then joined Corning Clinical Laboratories in 1995, which became Quest Diagnostics, Inc., where he served as Chief Medical and Science Officer, with responsibility for science, medicine and innovation. He joined Myriad Genetics, Inc. in 1998, where he was President of its diagnostic subsidiary, Myriad Genetic Laboratories, Inc. until March 2010, where he built Myriad Genetic Laboratories, Inc. into one of world's leading molecular diagnostic companies. He chaired the Governor's State Advisory Council on Science and Technology for the state of Utah in 2007. He has served and is serving as an independent director in industry association and various life science companies.